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Abstract
Purpose Substance use disorders and problematic substance
use are common problems in adolescence and young adult-
hood. Brief personalized feedback has been suggested for
treatment of alcohol and drug problems and poor mental
health. This repeated measurement randomized controlled tri-
al examines the effect of an interactive voice response (IVR)
system for assessing stress, depression, anxiety and substance
use.
Methods The IVR system was used twice weekly over
3 months after treatment initiation, with or without addition
of a personalized feedback intervention on stress and mental
health symptoms. Both IVR assessment only (control group)
and IVR assessment including feedback (intervention group)
were provided as an add-on to treatment-as-usual procedures
(TAU) in outpatient treatment of substance use problems in
adolescents and young adults (N = 73).
Results By using a mixed models approach, differences in
change scores were analyzed over the three-month assessment
period. Compared to the control group, the intervention group
demonstrated significantly greater improvement in the Arnetz
and Hasson stress score (AHSS, p = 0.019), the total
Symptoms Checklist 8 score (SCL-8D, p = 0.037), the SCL-
8D anxiety sub-score (p = 0.017), and on a summarized feed-
back score (p = 0.026), but not on the depression subscale.
There were no differences in global substance use scores
between the intervention group (feedback on mental health
symptoms) and the control group.
Conclusion In conclusion, IVR may be useful for follow-up
and repeated interventions as an add-on to regular treatment,
and personalized feedback could potentially improve mental
health in adolescents and young adults with problematic sub-
stance use.
Keywords Randomized controlled trial (RCT) . Interactive
voice response (IVR) . Outpatient treatment . Adolescents .
Youngadults .Substanceusedisorder .Mentalhealthproblems
Introduction
Substance use disorders are common in adolescence and
young adulthood, with lifetime prevalence rates around 8%
for alcohol use disorders and 2–3% for illicit drug use disor-
ders [1, 2]. Stress and mental health problems are associated
with substance use [3–5], and there is a considerable overlap
between substance use and mental health problems [6, 7], as
well as between substance use disorders and mental health
disorders [8–12]. Self-medication of psychiatric symptoms
may be a common pathway to substance use disorders in
adolescence [13].
Treatment retention is generally low among adolescents
and young adults treated for substance use [14]. Co-
occurring conditions increase severity and complicate recov-
ery [15, 16], and this has resulted in recommendations for
integrated treatment of substance use disorders and comorbid
conditions [17]. Recent reviews [18–20] have shown that in-
tegrated treatment is a promising approach, although the lim-
ited number of trials, inconsistent results, and difficulties of
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Relapse prevention [21] is an effective cognitive-
behavioral intervention approach recognizing the close rela-
tionship between affective states and substance use [22–24]. It
is designed to help individuals limit substance use associated
with high-risk situations, such as negative affective states,
during and after substance use treatment. The intervention
includes a continuing care approachwhere important elements
are support of self-control strategies, including identification
and awareness of early warning signals, and enhancement of
self-efficacy through feedback on the individual’s perfor-
mance [25, 26].
Brief interventions, in their shortest form, only include as-
sessment and clear and direct feedback, helping individuals
become more aware of risks and think differently about the
problematic behavior. Nevertheless, such interventions have
been used successfully to reduce substance use, improve men-
tal health, and increase motivation [27–29]. Providing mental
health and substance use patients with systematic and contin-
uous feedback during treatment is known to result in a positive
development over time [30, 31].
Computerized interventions have offered small but signif-
icant effect sizes on outcomes such as substance use, treatment
retention and adverse events, as well as improvements in ther-
apeutic alliance and engagement in treatment [32]. Interactive
voice response (IVR) is a well-established technology where a
central computer uses pre-programmed scripts to be used in
interaction with the user via their own mobile telephone hand-
set [33]. IVR could therefore be used as a brief cognitive
intervention on co-occurring affective states during substance
use treatment. In the field of substance use and misuse, IVR
has primarily been used for follow-up of substance use
[34–36], while only a few feasibility studies report actual in-
tervention results [37–40] and, to the best of the authors’
knowledge, no such study includes clinical samples of adoles-
cents and young adults.
IVR has several advantages over similar technology, such
as text messaging and smartphone applications, which have
also been used for assessments or considered for interventions
in the field of substance use [41, 42]. The IVR calls are natural
reminders that increase the probability of response. Collected
data are immediately secured on the server and can be used for
analysis and action. No information is stored on the handheld
device when using IVR, which is especially important when
handling sensitive information, such as the individual’s mental
health and substance use.
Our research group has used IVR to study the relation-
ship between alcohol consumption and daily stress, symp-
toms of depression and anxiety [43], and for brief automat-
ed alcohol interventions [44] in young adults. IVR has also
been used to monitor clinical samples of patients with men-
tal health problems in primary care [45], and adolescents
discharged from inpatient and outpatient psychiatric treat-
ment [46, 47].
In a recent study, we used IVR to give brief automated
feedback to prevent relapse in paroled offenders as add-on to
the regular supervision offered by the Prison and Probation
Services [48]. The study used a repeated-measures design
where IVR was used daily to monitor stress, mental health,
and substance use in participants over 30 consecutive days
following parole. The intervention group received immediate
feedback on the trend of summary scores for stress, mental
health and substance use variables, in conjunction with the
daily IVR assessments. The data were analyzed using linear
mixed models, and the intervention group showed greater im-
provement over time than the control group in the summary
scores, in mental health symptoms, in alcohol drinking, in
substance use, and in ratings of the most stressful everyday
events.
The present study in adolescents and young adults initiat-
ing substance-use treatment is based on our experiences from
our previous study in paroled offenders [48]. A repeated mea-
surement randomized controlled design was used to investi-
gate the effect of brief automated feedback on prevention
targeting co-occurring negative symptoms as an add-on to
substance use treatment. IVR assessments were made twice
weekly over a three-month period, and the feedback interven-
tion included stress and mental health variables to reduce
mental health problems and possibly also substance use. In a
previous report [49] only focusing on treatment retention, the
feedback interventions did not significantly improve treatment
retention; unplanned dropout was 24% in the intervention
group compared to 14% in the control group (P = 0.374).
No baseline data differed between dropouts and the others.
The aim of the present study was to investigate whether
adolescents and young adults in substance use treatment, who
were randomized to a brief automated feedback intervention
over a three-month assessment period, would show reductions
in symptoms of stress, depression, anxiety, and a total sum-
mary feedback score of these measures. Another aim was to
investigate whether a possible reduction of stress and symp-
toms would have an impact on simple substance-use scores
assessing intensity of alcohol and drug use. We hypothesized
that the feedback intervention on mental health symptoms
would directly improve these symptoms, and indirectly im-
prove substance use outcome.
Materials and Methods
Clinical Setting
Maria Malmö is an outpatient facility for treatment of sub-
stance use disorders and problematic substance use in
Malmö, Sweden. The target group is adolescents and young
adults, and the facility is managed by the social services and
the health care services. Staff from both the social services and
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from the local department of psychiatry collaborate on evalu-
ation and treatment, in compliance with national policies of a
divided treatment responsibility between these two organiza-
tions. The facility has an upper age limit of 25 years, but no
formal lower age limit. Treatment is an individualized psycho-
social treatment, including pharmacological treatment as
needed during early and protracted withdrawal. Further med-
ical assessment and treatment is available, as well as referrals
to further treatment or follow-up as necessary.
Design
The present study was a randomized controlled trial in ado-
lescents and young adults initiating treatment at the facility.
Patients included in the study entered a treatment-as-usual
(TAU) procedure with an add-on IVR, and were randomized
into two groups. One group received personalized feedback
on symptoms of stress, depression, and anxiety as part of the
IVR procedure (TAU + IVR assessment + IVR feedback,
i.e. the intervention group), and the other received IVR as-
sessment only (TAU + IVR assessment, i.e., the control
group). IVR in both groups was a twice-weekly assessment
over a 3-month period. In the end of each call, the interven-
tion group received a brief automated feedback on the de-
velopment of their individual reported levels of stress, de-
pression, and anxiety symptoms. The study was approved
by the Regional Ethics Committee at Lund University (file
number 2012-217), and was registered at ClinicalTrials.gov
(NCT01706380).
Participants were recruited between October 2012 and
December 2013. Patients were offered participation by the
counselor during the first or second visit to the clinic, during
which baseline assessment was carried out as part of
treatment-as-usual procedures. Staff did not offer participation
to patients with severe psychiatric disorders, severe intellectu-
al disability, and difficulties understanding the Swedish lan-
guage, and subjects would also be excluded if they could not
register a private cell-phone number. A cell-phone was chosen
because it was considered more private than a landline phone.
The number of subjects excluded was reported by study staff
to be low, and none were excluded due to inability to register a
cell-phone number.
Willing participants met with a research assistant to sign
written consent (from parent or guardians for those under the
age of 15), and for an automated telephone baseline assess-
ment, including registration of cell-phone number for use in
the trial. The randomization into two groups was based on a
1:1 random allocation sequence and a fixed-block size of ten
to ensure balanced study arms. All participants received com-
pensation of 100 SEK (around 12 USD) on entering the study
and another 100 SEK (12 USD) on formal completion of the
study after 12 weeks.
Assessment
The baseline assessment consisted of data derived from the
standard baseline assessment used at the facility. This was a
semi-structured Swedish questionnaire used in clinical assess-
ment of adolescents and young adults with substance use
problems, the adolescent version of the DOK documentation
system [50]. Variables included socio-demographic data, sub-
stance use history and psychiatric problems. For diagnostic
purposes, subjects were interviewed using the Mini
Neuropsychiatric Interview (MINI) [51].
The baseline assessment and automated telephone twice-
weekly IVR monitoring involved a total of 19 items, and one
supplementary item for those reporting drug uses. The first 15
items assessed stress and symptoms of poor mental health,
including depression and anxiety, and were summarized into
a total summary feedback score, with a Cronbach’s alpha co-
efficient ranging between 0.89 and 0.97 throughout the
follow-up period. Stress was measured with the Arnetz and
Hasson stress questionnaire (AHSS), which involves seven
items measuring common indices of stress [52]. In this study,
the Cronbach’s alpha coefficient ranged between 0.74 and
0.95, compared with 0.79 in the original study [52]. Anxiety
and depression were measured with the Symptoms Checklist
8D (SCL-8D) [53]. The Cronbach’s alpha coefficient on the
total scale ranged between 0.88 and 0.97 compared with 0.80
in the original study, and between 0.74 and 0.95 on both the
anxiety and depression subscales. All feedback items, i.e.
AHSS and SCL-8D, were scored on a 0 (bad) to 9 (good) digit
scale, so that increased scores indicated improved mental
health.
In addition to the feedback items, a global measure was
assessed to monitor the trajectory of alcohol and drug use
during the assessment period. Four items measured any alco-
hol use and any drug use on the present and preceding day,
where responses were given either as Bno^ (0) or Byes^ (1).
These four substance use variables were summarized into one
alcohol use sub-score and one drug use sub-score (with each
sub-score ranging from 0 to (2), and finally into one summa-
rized substance score (ranging from 0 to 4). For all substance
use variables, reduced scores indicate fewer days of substance
use.
Finally, participants who had reported any drug use either
on the present or preceding day were asked to record a mes-
sage specifying the type of drug used. This question was not
used in the present analyses, due to a low response rate.
Monitoring
The IVR system attempted to monitor participants in both
groups automatically, twice weekly over 12 weeks, thereby
giving potentially 24 follow-up assessments plus the baseline
assessment. Monitoring continued for 12 weeks regardless of
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whether participants continued treatment or treatment had
been discontinued. Attempts were made to monitor partici-
pants every second hour between noon and 8 pm on
Wednesdays and Thursdays (first weekly assessment), and
on Saturdays and Sundays (second weekly assessment). The
system was programmed to accept incoming calls from the
participants on the same days, so that assessments could also
be initiated directly by the participants. In both cases, i.e., both
for outgoing and incoming calls, the participant had to con-
firm identification by entering their personal 10-digit identifi-
cation number before hearing any information that could be
connected to the research project, or before responding to any
questions. When either of the two weekly assessments had
been completed, no further attempts were made until the next
scheduled weekly assessment. A text message (SMS) remind-
er was sent on Thursdays and Sundays at 11 am if the partic-
ipants had not completed the scheduled assessment by that
time. The SMS was brief and did not include information
about the research project (BHi, it’s Maria M. Wonder how
you are? Please call XXX-XX XX XX^).
Intervention
The intervention was inspired by relapse prevention and ap-
plied a brief intervention methodology. Participants in the in-
tervention group received automated telephone feedback im-
mediately after each follow-up assessment [48]. The feedback
intervention targeted awareness of stress and mental health as
potential triggers for substance use. It was based on a simple
calculation of the total summary score for the current assess-
ment, including the 15 items on stress and mental health
symptoms (see above), compared with the total score for the
same 15 items on the previous assessment. The respondent
was informed about whether the current result was positive,
negative, or neutral, after which the respondent was asked
whether they perceived their development as positive, nega-
tive, or neutral. In cases where the calculation and/or the re-
spondent indicated a negative direction, the respondent was
recommended to talk with someone they trusted, for example
their counselor at the treatment facility.
Statistics
Descriptive statistics are presented as mean values and asso-
ciated standard deviations (SD) for continuous variables, and
as frequencies (percentage) for categorical data. Baseline char-
acteristics of the participating subjects in the intervention
group and the control group were compared using the
Mann-Whitney test for continuous or ordinal variables and
Pearson’s chi-squared test (χ2) for categorical variables. The
study applied a repeatedmeasurement design and the outcome
measurements were the change in scores over a three-month
period (24 assessments) on the following variables: AHSS,
SCL-8D total score and sub-scores for anxiety and depression,
respectively, the summary (AHSS and SCL-8D) score, alco-
hol and drug use scores, respectively, and the summarized
substance use score. The outcome variables were analyzed
using a mixed models approach considering repeated mea-
sures, and where group (intervention vs. control), time (assess-
ment 1–24), age (below vs. above 18 years), and gender (male
vs. female) were entered as fixed effects, and subjects as ran-
dom effect (intercept) in the final model. In separate models,
time x group, MINI substance use diagnosis (present vs. ab-
sent), and MINI non-substance use diagnosis (present vs. ab-
sent) were entered as fixed effects. For repeated measure-
ments, an autoregressive covariance structure component (re-
lated to the individual’s repeatedly occurring responses) was
pre-specified. To minimize the missing data, missing values
from one or more items, including specific factor-representing
scores, were imputed using the mean value of the remaining,
non-missing, items. All statistical calculations were performed
using SPSS statistical software (IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp).
Results
Participants
As shown in Fig. 1, 367 subjects (30% women) were referred
to and received an initial appointment at the facility during the
recruitment period. Eighty patients (21%) did not turn up for
their initial appointment, and 52 (36%) chose to discontinue
treatment after one meeting and were not informed about the
study. The remaining 235 were potentially eligible for partic-
ipation in the study; of these, 158 did not participate, either
because they were never formally approached with an offer to
participate, or because they actively declined participation in
the study. Seventy-seven subjects agreed to participate, but
two subjects did not turn up for study assessments and another
two did not initiate the regular treatment at the facility.
The final number of subjects was 73 (20% of all potential
subjects), and these were randomized into the two groups, 36
into the control group (TAU + IVR assessment), and 37 into
the intervention group (TAU + IVR assessment + IVR feed-
back). During the 12 weeks assessment period, there was no
difference in number of days in treatment at the clinic between
the control group and the intervention group (76.0 ± 17.5 vs
70.4 ± 23.6, p = 0.377). The representativity of our sample
was analyzed by comparing baseline data [38] collected at the
facility as part of the standard procedure with data concerning
subjects not included in the study. These comparisons did not
identify significant differences in terms of gender or the type
of facility from which they were referred. Participants were
also compared with subjects applying for treatment through-
out the subsequent year (2014), and no significant differences
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were found in terms of gender, criminal convictions, or pri-
mary drug of abuse.
Baseline Data
The random allocation was successful as no significant base-
line differences were found between the two groups. As
shown in Table 1, there were no baseline differences in gender
distribution and mean age between the control group and the
intervention group. There were no significant differences be-
tween groups with respect to regular tobacco use, baseline
MINI substance use diagnosis, or MINI non-substance use
diagnosis.
Table 2 presents baseline data for the variables that were
used for the twice-weekly IVR assessments in both the control
group and the intervention group, including the variables that
were used for feedback in the intervention group. No baseline
differences were found.
Response Rates
Out of 1825 possible telephone assessments, 1009 (55.3%)
were completed, 55.1% in the control group and 55.5% in
the intervention group (p = 0.888). The total number of obser-
vations was 513 in the intervention group and 496 in the
control group. The number of missing responses for the eight
specific scores investigated varied between 3.1 and 7.4% in
the intervention group, and between 2.0 and 11.3% in the
control group. In the intervention group, 27–49% had at least
one item missing in any of the specific scores for poor mental
health, and the corresponding figure in the control group was
28–44%. At each complete assessment, numeric responses
could be given to a total of 19,171 questions, of which
18,735 (97.7%) were responded to, 97.7% in the control
group and 97.8% in the intervention group (p = 0.791). On
829 (82%) occasions, assessments were initiated by the IVR
system, while assessments were initiated by the respondent on
the remaining 180 occasions. Mean duration of the calls was
Fig. 1 Flow-chart
Table 1 By intervention group
(n = 73); baseline characteristics
of included subjects
Control group Intervention group p value
Number 36 37
Male gender 20 (56%) 27 (73%) 0.147
Age 18.1 (2.9) 17.7 (2.3) 0.772
Tobacco use 32 (89%) 26 (72%) 0.135
Any MINI diagnosis 33 (92%) 31 (84%) 0.479
MINI substance use disorder 33 (92%) 29 (78%) 0.190
Alcohol 7 (19%) 8 (22%) 1.000
Other substances 31 (86%) 28 (76%) 0.374
MINI non-substance-use diagnosis 24 (67%) 22 (59%) 0.630
Current depression 9 (25%) 10 (27%) 0.844
Agoraphobia 10 (28%) 7 (19%) 0.371
Generalized anxiety disorder 10 (28%) 10 (27%) 0.943
Antisocial personality disorder 12 (33%) 8 (22%) 0.262
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2.52 (SD 1.01) minutes in the intervention group (TAU + IVR
assessment + IVR feedback) and 2.21 (SD 0.57) minutes in
the control group (TAU + IVR assessment).
Intervention Effect
The results of the final linear mixed models are presented in
Table 3. Differences in change score over a three-month peri-
od (24 assessments) are shown for the intervention group
(TAU + IVR assessment + IVR feedback) and the control
group (TAU + IVR assessment) for the outcome variables.
Comparedwith the control group, the intervention group dem-
onstrated significantly greater improvement in AHSS stress
score (p = 0.019), in total SCL-8D score (p = 0.037), in the
anxiety subscale (p = 0.017), and in the total summary
feedback score (p = 0.026) over the study period. There was
no difference in change between the two groups on the SCL-
8D depression subscale included in the feedback. The global
substance use scores, not included in feedback, showed an
improvement, while there were no differences between inter-
vention and control group. These results were not altered
when controlling for a time x group factor, or when control-
ling for the presence of a substance use diagnosis or a psychi-
atric diagnosis other than substance use (data not shown).
Discussion
The main result is that subjects receiving personalized feed-
back onmental health had a significantly greater improvement
in scores of stress and anxiety symptoms during the assess-
ment period. This confirms previous positive results of con-
tinuous and systematic brief personalized interventions on
mental health variables, both in studies on relapse prevention
[22–24] and personalized feedback [27–31].
There was no difference in the effects on depressive symp-
toms between the intervention and control group, which is
consistent with some previous studies. In a study of patients
with treatment for comorbid substance use and mood and
anxiety disorders, an effect was seen for symptoms of stress
and a trend towards an effect on anxiety, while depression was
not altered [54]. Also, a previous study on a personalized
feedback intervention in depressed individuals indicated that
a favorable effect on depressivemoodmay bemore difficult to
obtain and may evolve only slowly [55]. Consequently, in
populations like the one studied here, it cannot be excluded
that depressive symptoms follow a different course in sub-
stance use treatment than symptoms of anxiety.
The positive results for symptoms of stress and anxiety did
not apply to substance use, which contradicts the hypothesis in
the present study. Previous research has presented inconsistent
results on the effects of interventions on co-occurring condi-
tions [18–20]. Here, possible reasons for the negative result
may be the limited extent of the intervention, a weak
Table 2 By intervention group
(n = 73); baseline values on the
variables used for daily
assessments (AHSS, SCL-8D,
alcohol, and drug use), a
summary feedback score, and a
summary substance use score, the
latter not used for feedback
Control group Intervention group p value
AHSS 42.1 (10.9) 42.8 (10.1) 0.969
SCL-8D 45.0 (19.2) 47.7 (15.3) 0.643
Anxiety 22.6 (10.5) 23.4 (9.0) 0.908
Depression 22.4 (9.6) 24.3 (7.4) 0.476
Total summary feedback score 87.2 (28.9) 90.5 (23.6) 0.817
Alcohol use 0.1 (0.5) 0.1 (0.3) 0.787
Drug use 0.3 (0.6) 0.2 (0.5) 0.734
Summary substance use score 0.4 (0.8) 0.3 (0.6) 0.925
Note: AHSS Arnetz and Hasson stress questionnaire, SCL-8D eight-item version of the Symptoms Check List
Table 3 By intervention group (n = 73); Mixed model analysis of
repeated measures
Estimate df t p value 95% CI
AHSS 4.49 64.84 2.41 0.019* 0.77, 8.21
SCL-8D 5.20 64.94 2.13 0.037* 0.32, 10.08
Anxiety 3.23 63.91 2.44 0.017* 0.59, 5.87
Depression 1.98 65.21 1.60 0.114 −0.49, 4.45
Total summary score 9.40 65.15 2.28 0.026* 1.16, 17.65
Alcohol use −0.02 50.77 −0.24 0.809 −0.15, 0.12
Drug use −0.07 56.18 −0.94 0.351 −0.23, 0.08
Total substance score −0.08 57.24 −0.08 0.452 −0.28, 0.13
Results presenting the difference in change over a 3-month assessment
period (12 assessments) between the intervention group (TAU + IVR
assessment + IVR feedback) and the control group (TAU + IVR assess-
ment) on the following outcome variables: stress (AHSS), mental health
symptoms (SCL-8D), SCL-8D sub-scores for anxiety and depression, the
summary total score (including AHSS and SCL-8D) used for feedback in
the intervention group, and a summarized total substance use score (in-
cluding alcohol and drug use), the latter not used for feedback
AHSS Arnetz and Hasson stress questionnaire, SCL-8D eight-item ver-
sion of the Symptoms Check List
*p < 0.05
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relationship between the studied variables, or that identified
improvements were not sufficient to influence substance use.
Furthermore, the intervention period of 3 months was short.
The result might also depend on our global assessment of
substance use, i.e., the fact that we only assessed use (yes or
no) on the current and preceding day. The dichotomized ques-
tions about alcohol and drugs may have been too unspecific to
capture changes in consumption, compared to the 10-digit
scale used in the study in paroled offenders [48]. A significant
difference between the two studies is that the feedback in the
previous study included substance use variables. Inclusion of
substance use in the present feedback might have resulted in
reduced substance use, as in the study on paroled offenders
[48]. It should be underlined that our intervention was given as
an add-on to the regular substance use treatment given to both
groups. Both groups had equal reductions in substance use,
which is probably a result of the regular treatment.
In the field of substance use disorders, among several IVR
studies [34–36], few studies have reported intervention results
[37–40]. The present study and our previous study on paroled
offenders [48] are the first studies to report positive interven-
tion effects from a continuous-care, brief personalized feed-
back intervention delivered by IVR, in vulnerable populations
with a high degree of substance use and mental health prob-
lems. The personalized IVR feedback method, inspired by
relapse prevention, used in both our studies holds promise as
a potential add-on in the treatment of mental health problems
in populations with problematic substance use or criminal
behavior. More research is needed to examine whether the
potential effect of this technique can be generalized to other
settings and populations suffering from mental health prob-
lems and substance use problems.
The vulnerability of the study population is demonstrated
by the high percentage of participants who fulfilled criteria for
at least one MINI psychiatric disorder (other than substance
use disorders) at baseline. Sixty-three percent of the subjects
in the present study met criteria for at least one DSM-IV di-
agnosis other than substance use disorders included in the
MINI interview. This clinical picture is consistent with previ-
ous data. In a literature review, Armstrong and Costello [8]
showed that 60% of adolescents with substance use problems
in clinical samples had comorbid psychiatric diagnoses. In the
Swedish setting, a study from a different center demonstrated
that 81 to 90% of adolescents seeking treatment for substance
use problems fulfilled criteria for another mental disorder [11].
Based on this comparison, the findings from the present
dataset regarding psychiatric comorbidity are likely to be gen-
eralizable to other groups of young people with problematic
substance use.
The main strengths of the study are the randomized con-
trolled design and that it shows a positive therapeutic effect on
the symptoms that are common and central to young popula-
tions with substance abuse/dependence. The repeated
measures design and use of mixed models is also a strength,
offering statistical power when analyzing how outcomes
change over time when affected by the feedback intervention
[56].
All participants in the present study had access to their own
cell-phone. The frequent use of cell-phones means that both
follow-up and interventions can easily be implemented in ad-
olescents and young adults in substance use treatment.
Adverse events from IVR contact were not measured system-
atically, but none were mentioned spontaneously in follow-up
assessments for patients remaining throughout the 12-week
study period. Also, given the low level of complexity of the
present follow-up and assessment technique, it can be as-
sumed that any adverse events are mild.
The present study also has some limitations. The first and
most important is the high rate of attrition preceding the ran-
dom assignment to a group; this may have affected the results.
Only 73 out of 367 patients (20%) entering the facility could
be included in the study. One factor that might have contrib-
uted to attrition is that final inclusion in the study was arranged
at a separately scheduled meeting with a research assistant.
However, no major differences could be identified when com-
paring those initiating contact with the treatment facility and
those finally participating in the study, and the population
seems to be representative to similar populations [8].
A second limitation concerns the measurements of sub-
stance use. While the self-reported scores in the present study
did not demonstrate significant improvement in the interven-
tion group, systematic data for an objective follow-up mea-
surement of substance use were not available in the present
study.
A third inherent limitation of an automated telephonemeth-
od is the limited amount of information that can be obtained
during each assessment. This method favors the use of brief
symptom scales rather than diagnostic tools, so symptoms
such as psychotic manifestations could not be assessed over
time in this study. However, the feasibility of using the present
method, along with the potentially favorable results displayed
here, holds promise as a method for frequent follow-up of
briefly measured symptom scores, including central compo-
nents such as depressive symptoms, anxiety, and stress.
A fourth limitation concerns analysis of the twice-weekly
assessments that contained missing data. We used imputation
for these missing values. These imputed values gave us gains
in terms of a larger sample size and statistical power, but also a
loss in the quality of data since imputation cannot replace
missing information. Since the items included in each score
are strongly or reasonably correlated to each other, we believe
that the gain may outweigh any disadvantages.
In conclusion, a personalized feedback added to IVR as-
sessments was a useful intervention for stress and anxiety
during treatment for substance use disorders and problematic
substance use in adolescents and young adults. The addition
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of automated personalized feedback may be a promising tool
in alleviating mental health symptoms during treatment, al-
though more remains to be studied about its potential role in
treating the actual substance use disorder. If the findings can
be replicated in future work, implications for adolescents and
young adults with substance use problems may be significant.
Acknowledgements Participation: We would like to acknowledge all
adolescents and young adults participating in the study, as well as team
leader Maria Almazidou and her staff at the Maria Malmö outpatient
facility. Research assistant: Mikael Olausson, Region Skåne.
Programming: Milo Fryling, TeleSage, Chapel Hill, N.C., USA.
Statistical advice: Håkan Lövkvist, PhD/medical statistician, Unit for
Medical Statistics and Epidemiology, Skåne University Hospital,
Sweden. The IVR prompts were recorded by Karin Öjehagen.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflict of
interest.
Ethical Approval All procedures were in accordance with the ethical
standards of the regional research committee and with the 1964 Helsinki
declaration and its later amendments or comparable ethical standards.
Informed Consent Informed consent was obtained for all individual
participants in the study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE.
Monitoring the Future National Results on Adolescent Drug Use:
Overview of Key Findings. 2007; Bethesda, MD: National Institute
on Drug Abuse.
2. Merikangas KR, McClair VL. Epidemiology of substance use dis-
orders. Hum Genet. 2012;131:779–89.
3. Mason MJ. Mental health, school problems, and social networks:
modeling urban adolescent substance abuse. J Prim Prev. 2010;31:
321–31.
4. Low NCP, Dugas E, O'Loughlin E, Rodriguez D, Contreras G,
Chaiton M, O'Loughlin J. Common stressful life events and diffi-
culties are associated with mental health symptoms and substance
use in young adolescents. BMC Psychiatry. 2012;12
5. Tavolacci MP, Grigioni S, Richard L, Villet H, Dechelotte P.
Prevalence and association of perceived stress, substance use and
behavioral addictions: a cross-sectional study among university
students in France, 2009-2011. BMC Public Health. 2013;13(724)
6. Patel V, Flisher AJ, Hetrick S, McGorry P. Mental health of young
people. A global public-health challenge. Lancet. 2007;369:1302–
13.
7. Toumbourou JW, Stockwell T, Neighbors C, Marlatt GA, Sturge J,
Rehm J. Interventions to reduce harm associated with adolescent
substance use. Lancet. 2007;369:1391–401.
8. Armstrong TD, Costello EJ. Community studies on adolescent sub-
stance use, abuse, or dependence and psychiatric comorbidity. J
Consult Clin Psychol. 2002;70:1224–39.
9. Bakken K, Landheim AS, Vaglum P. Early and late onset groups of
substance misusers: differences in primary and secondary psychiat-
ric disorders. J Subst Use. 2004;9:224–34.
10. Trim RS, Meehan BT, King KM, Chassin L. The relation between
adolescent substance use and young adult internalizing symptoms:
findings from a high-risk longitudinal sample. Psychol Addict
Behav. 2007;21:97–107.
11. Hodgins S, Tengström A, Bylin S, Göranson M, Hagen L, Janson
M, Larsson A, Lundgren-Andersson C, Lundmark C, Norell E,
Pedersen H. Consulting for substance abuse: mental disorders
among adolescents and their parents. Nord J Psychiatry.
2007;61(5):379–86.
12. Larm P, Hodgins S, Tengström A, Larsson A. Trajectories of resil-
ience over 25 years of individuals who as adolescents consulted for
substance misuse and a matched comparison group. Addiction.
2010;105(7):1216–25.
13. Wolitsky-Taylor K, Bobova L, Zinbarg RE, Mineka S, Craske MG.
Longitudinal investigation of the impact of anxiety and mood dis-
orders in adolescence on subsequent substance use disorder onset
and vice versa. Addict Behav. 2012;37:982–5.
14. SAMHSA, Substance Abuse and Mental Health Services
Administration. Results from the 2010 National Survey on Drug
Use and Health: Summary of National Findings. Rockville, MD:
Substance Abuse and Mental Health Services Administration;
2011. NSDUH Series H-41, HHS publication (SMA) 11–4658.
15. Daley, DC., Moss, HM. Dual disorders: Counseling clients with
chemical dependency and mental illness. 2002 (3rd ed.). Center
City, MN: Hazelden.
16. Grella CE, Hser YI, Joshi V, Rounds-Bryant J. Drug treatment
outcomes for adolescent with comorbid mental and substance use
disorders. J Nerv Ment Dis. 2001;189(6):384–92.
17. Jané-Llopis E, Matytsina I. Mental health and alcohol, drugs and
tobacco: a review of the comorbidity between mental disorders and
the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev.
2006;25(6):515–36.
18. Hesse M. Integrated psychological treatment for substance use and
co-morbid anxiety or depression vs. treatment for substance use
alone. A systematic review of the published literature. BMC
Psychiatry. 2009;9(6) doi:10.1186/1471-244X-9-6.
19. Kelly TM, Daley DC. Integrated treatment of substance use and
psychiatric disorders. Soc Work Public Health. 2013;28(0):388–
406.
20. McHugh RK. Treatment of co-occurring anxiety disorders and sub-
stance use disorders. Harv Rev Psychiatry. 2015;23(2):99–111.
21. Marlatt GA, Gordon JR. Relapse prevention: maintenance strate-
gies in the treatment of addictive behaviors. New York: Guilford
Press; 1985.
22. Carroll KM. Prevention as a psychosocial treatment: a review of
controlled clinical trials. Exp clinical. Psychopharmacol. 1996;4:
46–54.
23. Irvin JE, Bowers CA, Dunn ME, Wang MC. Efficacy of relapse
prevention: a meta-analytic review. J Consult Clin Psychol.
1999;67(4):563–70.
24. Lancaster TM, Hajek P, Stead LF, West R, Jarvis MJ. Prevention of
relapse after quitting smoking: a systematic review of trials. Arch
Intern Med. 2006;166(8):828–35.
25. Hendershot CS, Witkiewitz K, George WH, Marlatt GA. Relapse
prevention for addictive behaviors. Subst Abuse Treat Prev Policy.
2011;19(6):Article17. doi:10.1186/1747-597X-6-17.
26. Larimer ME, Palmer RS, Marlatt GA. Relapse prevention: an over-
view of Marlatt’s cognitive-behavioral model. Alcohol Res Health.
1999;23(2):151–60.
Int.J. Behav. Med.
27. Martin G, Copeland J. The adolescent cannabis check-up: random-
ized trial of a brief intervention for young cannabis users. J Subst
Abus Treat. 2008;34:407–14.
28. Knaup C, Koesters M, Schoefer D, Becker T, Puschner B. Effect of
feedback of treatment outcome in specialist mental healthcare: me-
ta-analysis. British J Psych. 2009;195(1):15–22.
29. White A, Kavanagh D, Stallman H, Klein B, Kay-Lambkin F,
Proudfoot J, Drennan J, Connor J, Baker A, Hines E, Young R.
Online alcohol interventions: a systematic review. J Med Internet
Res. 2010;12(5):e62. doi:10.2196/jmir.1479. PMID: 21169175.
PMCID: PMC3057310.URL: https://www.jmir.org/2010/5/e62.
30. Cacciola JS, Meyers K, Bates SE, Rosenwasser B, Arria AM,
McLellan T. Assessing adolescent substance abuse programs with
updated quality indicators: the development of a consumer guide
for adolescent treatment. J Child Adolesc Subst Abuse. 2015;24(3):
142–54.
31. Shimokawa K, Lambert MJ, Smart DW. Enhancing treatment out-
come of patients at risk of treatment failure: meta-analytic and
mega-analytic review of a psychotherapy quality assurance system.
J Consult Clin Psychol. 2010;78(3):298–311.
32. Takano A, Miyamoto Y, Matsumoto TA. Review about new ap-
proaches using the internet and computer technology for people
with drug use disorder. Nihon Arukoru Yakubutsu Igakkai Zasshi.
2015;50(1):19–34.
33. Corkrey R, Parkinson L. Interactive voice response: review of stud-
ies 1989-2000. Behav Res Methods. 2002;34:342–53.
34. Kaminer Y, Litt MD, Burke RH, Burleson JA. An interactive voice
response (IVR) system for adolescents with alcohol use disorders: a
pilot study. Am J Addict. 2006;15:122–5.
35. Burleson JA, Kaminer Y. Aftercare for adolescent alcohol use dis-
order: feasibility and acceptability of a phone intervention. Am J
Addict. 2007;16(3):202–5.
36. Helzer JE, Rose GL, Badger GJ, Searles JS, Thomas CS, Lindberg
SA, Guth S. Using interactive voice response to enhance brief al-
cohol intervention in primary care settings. J Stud Alcohol Drugs.
2008;69(2):251–8.
37. Mosavel M. The use of a telephone-based communication tool by
low-income substance abusers. J Health Commun. 2005;19:451–
211.
38. Brown RL, Saunders LA, Bobula JA, Mundt MP, Koch PE.
Randomized-controlled trial of a telephone and mail intervention
for alcohol use disorders: three-month drinking outcomes. Alcohol
Clin Exp Res. 2007;31(8):1372–9.
39. Rose GL, Skelly JM, Badger G, MacLean CD, Malgeri MP, Helzer
JE. Automated screening for at-risk drinking in a primary care of-
fice using interactive voice response. J Stud Alcohol Drugs.
2010;71:734–8.
40. Moore BA, Fazzino T, Barry DT, Fiellin DA, Cutter CJ,
Schottenfeld RS, Ball SA. The recovery line: a pilot trial of auto-
mated telephone-based treatment for continued drug use in metha-
done maintenance. J Subst Abus Treat. 2013;45:63–9.
41. Mason M, Ola B, Zaharakis N, Zhang J. Text messaging interven-
tions for adolescent and young adult substance use: a meta-analysis.
Prev Sci. 2015;16:181–8.
42. Dahne J, Lejuez CW. Smartphone and mobile application utiliza-
tion prior to and following treatment among individuals enrolled in
residential substance use treatment. J Subst Abus Treat. 2015;58:
95–9.
43. Andersson C, Söderpalm Gordh AH, Berglund M. Use of real-time
interactive voice response in a study of stress and alcohol consump-
tion. Alcohol Clin Exp Res. 2007;31(11):1908–12.
44. Andersson C. Comparison of web and interactive voice response
(IVR) methods for delivering brief alcohol interventions to
hazardous-drinking university students: a randomized controlled
trial. Eur Addict Res. 2015;21(5):240–52.
45. Strid C, Andersson C, Forsell Y, Öjehagen A, Lundh L-G. Internet-
based cognitive behavior therapy and physical exercise - effects
studied by automated telephone assessments in mental ill-health
patients. Br J Psychology. 2016; doi:10.1111/bjc.12111.
46. Johansson BA, Remvall S, Malgerud R, Lindgren A, Andersson C.
Interactive voice response—an automated follow-up technique for
adolescents discharged from acute psychiatric inpatient care: a
randomised controlled trial. SpringerPlus. 2013;2:146.
doi:10.1186/2193-1801-2-146.Published online Apr 8, 2013
47. Andersson C, Danielsson S, Silverberg-Dymling G, Löndahl G,
Johansson BA. Evaluation of Interactive Voice Response (IVR)
and postal survey in follow-up of children and adolescents
discharged from psychiatric outpatient treatment: a randomized
controlled trial. SpringerPlus. 2014;3:77.
48. Andersson C, Vasiljevic Z, Höglund P, Öjehagen A, Berglund M.
Daily automated telephone assessment and intervention improved
1-month outcome in paroled offenders. Int J Offender Ther Comp
Criminol. 2014;2014:13.
49. Linvik J. Predictors for negative treatment outcomes among ado-
lescents with substance use problems. Lund University, Faculty of
Medicine; 2015.
50. Jenner H, Segraeus V. The Swedish DOC system—an attempt to
combine documentation and self-evaluation. Eur Addict Res.
2005;11:186–92.
51. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J,
Weiller E, Hergueta T, Baker R, Dunbar GC. The mini-
international neuropsychiatric interview (M.I.N.I.): the develop-
ment and validation of a structured diagnostic psychiatric interview
for DSM-IVand ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–
33. quiz 34-57
52. Andersson C, Johnsson KO, Berglund M, Ojehagen A.
Measurement properties of the Arnetz and Hasson stress question-
naire in Swedish university freshmen. Scand J Public Health.
2009;37(3):273–9.
53. Fink P, Jensen J, Borgquist L, Brevik JI, Dalgard OS, Sandager I,
Engberg M, Hansson L, Holm M, Joukamaa M, Karlsson H,
Lehtinen V, Nettelbladt P, Nordström G, Stefansson CG, Sörensen
L, Munk-Jörgensen P. Psychiatric morbidity in primary public
health care: a Nordic multicenter investigation. Part 1: method
and prevalence of psychiatric morbidity. Acta Psych Scand.
1995;92(6):409–18.
54. Milosevic I, Chudzik SM, Boyd S, McCabe RE. Evaluation of an
integrated group cognitive-behavioral treatment for comorbid
mood, anxiety, and substance use disorders: A pilot study. J
Anxiety Disord 2016 [e-pub ahead of print]
55. Hartmann JA, Wichers M, Menne-Lothmann C, Kramer I,
ViechtbauerW, Peeters F, et al. Experience sampling-based person-
alized feedback and positive effect: a randomized controlled trial in
depressed patients. PLoS One. 2015;10:e0128095.
56. Detry MA, Ma Y. Analyzing measurements using mixed models.
JAMA. 2016;315(4):407–8.
Int.J. Behav. Med.
